476 related articles for article (PubMed ID: 37627173)
21. Remodeling of tumor stroma and response to therapy.
Johansson A; Ganss R
Cancers (Basel); 2012 Mar; 4(2):340-53. PubMed ID: 24213314
[TBL] [Abstract][Full Text] [Related]
22. Cancer-associated fibroblasts from invasive breast cancer have an attenuated capacity to secrete collagens.
Fu Z; Song P; Li D; Yi C; Chen H; Ruan S; Shi Z; Xu W; Fu X; Zheng S
Int J Oncol; 2014 Oct; 45(4):1479-88. PubMed ID: 25070059
[TBL] [Abstract][Full Text] [Related]
23. Emerging nanomedicines for anti-stromal therapy against desmoplastic tumors.
Han X; Xu Y; Geranpayehvaghei M; Anderson GJ; Li Y; Nie G
Biomaterials; 2020 Feb; 232():119745. PubMed ID: 31918228
[TBL] [Abstract][Full Text] [Related]
24. Antifibrotic therapy to normalize the tumor microenvironment.
Hauge A; Rofstad EK
J Transl Med; 2020 May; 18(1):207. PubMed ID: 32434573
[TBL] [Abstract][Full Text] [Related]
25. The role of tumor-stroma interactions on desmoplasia and tumorigenicity within a microengineered 3D platform.
Saini H; Rahmani Eliato K; Veldhuizen J; Zare A; Allam M; Silva C; Kratz A; Truong D; Mouneimne G; LaBaer J; Ros R; Nikkhah M
Biomaterials; 2020 Jul; 247():119975. PubMed ID: 32278213
[TBL] [Abstract][Full Text] [Related]
26. Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy.
Barrett RL; Puré E
Elife; 2020 Dec; 9():. PubMed ID: 33370234
[TBL] [Abstract][Full Text] [Related]
27. The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategies.
Wei J; Yao J; Yan M; Xie Y; Liu P; Mao Y; Li X
Acta Biomater; 2022 Sep; 150():34-47. PubMed ID: 35948177
[TBL] [Abstract][Full Text] [Related]
28. Strategies of targeting pathological stroma for enhanced antitumor therapies.
Zhu Y; Yu F; Tan Y; Yuan H; Hu F
Pharmacol Res; 2019 Oct; 148():104401. PubMed ID: 31422113
[TBL] [Abstract][Full Text] [Related]
29. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer.
Bremnes RM; Dønnem T; Al-Saad S; Al-Shibli K; Andersen S; Sirera R; Camps C; Marinez I; Busund LT
J Thorac Oncol; 2011 Jan; 6(1):209-17. PubMed ID: 21107292
[TBL] [Abstract][Full Text] [Related]
30. Insidious changes in stromal matrix fuel cancer progression.
Miles FL; Sikes RA
Mol Cancer Res; 2014 Mar; 12(3):297-312. PubMed ID: 24452359
[TBL] [Abstract][Full Text] [Related]
31. Biopolymer-based tumor microenvironment-responsive nanomedicine for targeted cancer therapy.
Jha A; Kumar M; Bharti K; Manjit M; Mishra B
Nanomedicine (Lond); 2024 Mar; 19(7):633-651. PubMed ID: 38445583
[TBL] [Abstract][Full Text] [Related]
32. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
Suzuki J; Tsuboi M; Ishii G
Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
[TBL] [Abstract][Full Text] [Related]
33. An Engineered Breast Cancer Model on a Chip to Replicate ECM-Activation In Vitro during Tumor Progression.
Gioiella F; Urciuolo F; Imparato G; Brancato V; Netti PA
Adv Healthc Mater; 2016 Dec; 5(23):3074-3084. PubMed ID: 27925458
[TBL] [Abstract][Full Text] [Related]
34. Fabrication Method of a High-Density Co-Culture Tumor-Stroma Platform to Study Cancer Progression.
Saini H; Nikkhah M
Methods Mol Biol; 2021; 2258():241-255. PubMed ID: 33340365
[TBL] [Abstract][Full Text] [Related]
35. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness.
Zhang JY; Zhu WW; Wang MY; Zhai RD; Wang Q; Shen WL; Liu LK
J Transl Med; 2021 Dec; 19(1):513. PubMed ID: 34930321
[TBL] [Abstract][Full Text] [Related]
36. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
37. Capturing the spatial and temporal dynamics of tumor stroma for on-chip optimization of microenvironmental targeting nanomedicine.
Imparato G; Urciuolo F; Mazio C; Netti PA
Lab Chip; 2022 Dec; 23(1):25-43. PubMed ID: 36305728
[TBL] [Abstract][Full Text] [Related]
38. Uncovering Tumor-Stroma Inter-relationships Using MALDI Mass Spectrometry Imaging.
Boyle ST; Mittal P; Kaur G; Hoffmann P; Samuel MS; Klingler-Hoffmann M
J Proteome Res; 2020 Oct; 19(10):4093-4103. PubMed ID: 32870688
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses.
Everts A; Bergeman M; McFadden G; Kemp V
Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33167307
[TBL] [Abstract][Full Text] [Related]
40. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
